作者: Gunter Deppe , Ismail Mert , Jimmy Belotte , Ira S. Winer
DOI: 10.1007/S00508-013-0338-Y
关键词:
摘要: Squamous cell carcinoma of the vulva is a rare disease with good prognosis if diagnosed early. The standard primary therapy surgery. Neoadjuvant radiation or chemotherapy has been used to achieve resectability tumor and decrease radicality Chemotherapy platinum compounds, paclitaxel targeted (erlotinib) shown activity. International collaborative trials are needed identify best therapeutic strategy for patients squamous cancer who not candidates surgery concomitant chemoradiation. We review various treatment options available advanced recurrent vulva.